Dosidal · Switzerland

Gliclazid retard Zentiva 30 mg, Retardtabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:58740 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 58740
atc: A10BB09
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2008-10-15
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A10BB09
authorisation_number: 58740
form: RETT
holder: Helvepharm AG
holder_partner_nr: 1000513
it_number: 07.06.2.
name: Gliclazid retard Zentiva 30 mg, Retardtabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
1rsLqOWNZyIFWC8OAyseU8VlFryxmhUUI8VW1g0AZrZpHwKhEZuMQf0YgYY2tSGZB-l_dkAcZUnxi4PmL6MZkQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:58740 · Related records in other markets · Dosidal